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Objective To compare the prenatal frame of reference of omphalocele (i.e. survival of fetuses) with 
that after birth (i.e. survival of liveborn neonates), and to assess physical growth and neurodevelopment in 
children with minor or giant omphalocele up to two years of age. 
Design  We included fetuses and neonates diagnosed 2000-2012. Physical growth (SD scores, SDS) 
and mental and motor development at 12 and 24 months were analysed using general linear models, and 
outcomes were compared with reference norms. Giant omphalocele was defined as defect ≥5cm, with liver 
protruding. 
Results  We included 145 fetuses and neonates. Of 126 (87%) who were diagnosed prenatally, 50 
(40%) were liveborn, and 35 (28%) survived at least two years. Nineteen (13%) neonates were diagnosed 
after birth. Of the 69 liveborn neonates, 52 (75%) survived, and 42 children (81% of survivors) were 
followed longitudinally. At 24 months, mean [95% CI] height and weight SDS were significantly below 0 in 
both minor (height: -0.57 [-1.05, -0.09]; weight: -0.86 [-1.35, -0.37]) and giant omphalocele (height: -1.32 [-
2.10, -0.54]; weight: -1.58 [-2.37, -0.79]). Mental development was comparable to reference norms in both 
groups. Motor function delay was found significantly more often in children with giant omphalocele (82%) 
than in those with minor omphalocele (21%, p=0.002). 
Conclusions The prenatal and postnatal frame of reference of omphalocele differ considerably; a 
multidisciplinary approach in parental counselling is recommended. As many children with giant 
omphalocele had delayed motor development, we recommend close monitoring of these children and early 
referral to physical therapy. 




Omphalocele is a midline congenital abdominal wall defect (AWD) with an estimated prevalence of 3.38 per 
10,000 pregnancies.(1) It is usually defined as 'giant' if the defect is ≥5 cm at birth, with the liver (partly) 
protruding.(2) Otherwise, it is called 'minor'.   
Nowadays, over 90% of omphaloceles are diagnosed prenatally.(3) Isolated omphalocele, which 
presents approximately 20%, usually has a high survival rate of 90%.(4) Other fetuses, however, present 
with chromosomal abnormalities and/or associated congenital anomalies (non-isolated omphalocele)(4), 
which lead to a high prevalence of termination of pregnancy (TOP) and intra-uterine death (IUD). 
Therefore, we hypothesize a striking difference between the frame of reference of prenatal specialists and 
that of paediatric surgeons and paediatricians.  
Previous research on long-term outcome mainly focused on children with giant omphalocele,(5-7) 
or surprisingly did not differentiate between gastroschisis and omphalocele.(8-10) We expect normal 
growth and development in non-syndromic children with minor omphalocele, and delayed growth and 
motor development in those with giant omphalocele. 
The aim of our study was to 1) compare the prenatal frame of reference of omphalocele with that 
after birth, and 2) assess physical growth and neurodevelopment in children with minor or giant 
omphalocele up to two years of age. 
METHODS 
Study population 
We retrospectively analysed data of all fetuses and neonates diagnosed with omphalocele between 1 
January 2000 and 31 December 2012 at the Erasmus Medical Centre-Sophia Children's Hospital Rotterdam. 
All parents of survivors were offered to enter their child in the longitudinal prospective follow-up 
programme for children with anatomical congenital anomalies treated in our hospital.(11) The Medical 





Variables and definitions 
Following prenatal detection of omphalocele, a prenatal specialist further examined the fetus to identify 
possible additional structural anomalies; karyotyping was offered in all fetuses. We classified additional 
anomalies by prognosis as follows: lethal (e.g. trisomy 18; anencephaly), very poor (e.g. congenital 
diaphragmatic hernia; large encephalocele) or uncertain (e.g. suspected intestinal atresia; congenital heart 
defect). Fetuses with isolated omphalocele were categorised according to the ratio of omphalocele 
circumference to abdominal circumference (OC/AC-ratio (<0.82 or ≥0.82) at their first prenatal 
ultrasound.(12)  
All fetuses were delivered vaginally, unless obstetric reasons required otherwise. Neonates with a 
birth weight <10th centile of Dutch references curves were considered small for gestational age.(13) 
Neonates born <37 weeks' gestation were considered preterm. Socioeconomic status scores (population 
mean 0, SD 1) were based on postal codes.(14, 15) 
After birth, the omphalocele was defined as ‘giant’ if the defect diameter was ≥5cm with liver 
protruding. All neonates were screened for multiple congenital anomalies (MCA); we documented those 
requiring surgery or multiple follow-up visits. Chronic lung disease was diagnosed in neonates who required 
supplemental oxygen for at least 28 days.(16)  
We documented duration of initial mechanical ventilation, time to full enteral feeding (TFEF), 
presence of intestinal failure (i.e. TFEF ≥6 weeks), and length of initial hospital stay. If these exceeded two 
years, data were documented as 730 days. 
Neonatal death was defined as death during the first 28 days of life, and infant death as death 
between 28 days and one year.   
Physical growth and neurodevelopment 
Height and weight had been measured at 12 and 24 months of age (corrected for preterm birth), and head 
circumference at 12 months of age. We calculated standard deviation scores (SDS) according to Dutch 
reference norms; -2 to +2 SD was considered normal range.(17) Mental and motor development had been 
assessed at 12 and 24 months using the Bayley Developmental Scales (BOS 2-30, Dutch version)(18) and, 
from December 2003, Bayley Scales of Infant Development-Second Edition (BSID-II-NL).(19) These scales 
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are interchangeable,(19) and provide a mental developmental index (MDI) and psychomotor 
developmental index (PDI) with a mean of 100 and SD of 15.(18, 19) Scores <55 are indicative of severe 
developmental delay; those were documented as 55. We excluded children with a confirmed syndrome 
influencing physical growth, neurodevelopment or both from the respective analysis. 
Statistical analysis 
Categorical variables are presented as number (%) and continuous variables as median (interquartile range, 
IQR). Prenatal, perinatal and postnatal characteristics of children with minor or giant omphalocele were 
compared using Fisher's exact tests for categorical data, and Mann-Whitney tests for continuous data. We 
used general linear models to analyse the course of height, weight and neurodevelopment over time. These 
models included type of defect (minor or giant), the time point (12 or 24 months) and their interaction 
term as independent variables. We used an unstructured error covariance matrix for the repeated 
measurements of each child to account for the within-subject correlations. The results are presented as 
estimated marginal means (i.e. the predicted values of the dependent variable, adjusted for covariates in 
the model) with their 95% confidence intervals (CI). A two-sided p-value of <0.05 was considered 
statistically significant. Statistical analyses were performed using SPSS V.21.0. 
RESULTS 
We included 145 fetuses and neonates; 126 (87%) were diagnosed prenatally, 50 (40%) of them were 
liveborn. Nineteen (13%) neonates were diagnosed postnatally. Of all 69 liveborn neonates, 52 (75%) 
survived at least two years (Figure 1). Follow-up data of 42 (81%) children were analysed; all but three were 
seen at both time points (Figure 2). Prenatal, perinatal and postnatal characteristics of children who 




Figure 1. Flowchart of survival in all omphalocele fetuses and neonates 
TOP: termination of pregnancy; IUD: intrauterine death; OC/AC: omphalocele circumference / abdominal 
circumference; NND: neonatal death. 1 2/126 were diagnosed late in pregnancy (1 at day of birth: MCA (suspected 
intestinal atresia), 1 at 34 weeks’ gestation: isolated, but limited imaging due to severe polyhydramnios and maternal 
obesity); 2 1/19 prenatally diagnosed with gastroschisis instead of ruptured omphalocele; 3 Including one ruptured 




Figure 2. Flowchart of children with omphalocele included in follow-up analyses of physical growth and 
neurodevelopment 
* Reasons for missing data on growth at 12 months: excluded because of Beckwith-Wiedemann Syndrome (n=5); 
organisational (n=1). At 24 months: excluded because of Beckwith-Wiedemann Syndrome (n=5). 
Reasons for missing data on development at 12 months: refusal n=1 (both mental/motor); non-cooperative n=1 
(motor); immobilisation of legs n=1 (motor); organisational n=1 (motor). At 24 months: refusal n=1 (both 
mental/motor); non-cooperative n=10 (both mental/motor n=3; mental n=1; motor n=6) 
 
Prenatal frame of reference 
Overall, 50/126 (40%) fetuses diagnosed with omphalocele were liveborn, and 35 (28%) survived ≥2 years. 
Additional structural or chromosomal anomalies were found in 71/126 (56%) fetuses. Most of these 
anomalies were lethal (42/71 (59%); Figure 1). Two fetuses classified as having a lethal prognosis were 
liveborn but died shortly after birth. Thirteen fetuses had a very poor prognosis; 6/13 (46%) couples 
continued the pregnancy, which resulted in four livebirths of whom one child survived. Sixteen fetuses had 
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an uncertain prognosis; 8/16 (50%) couples decided to continue the pregnancy; two fetuses died in utero 
and 5/6 liveborn neonates survived.  
 Isolated omphalocele was diagnosed in 55/126 (44%) fetuses. Thirty of them (55%) had OC/AC 
<0.82 and 26/30 (87%) were liveborn, compared to 12/25 (48%) fetuses with OC/AC ≥0.82 (p=0.003). With 
TOPs excluded, 93% versus 71% of continuing pregnancies resulted in livebirth, respectively (p=0.086). Of 
38 liveborn neonates with an isolated omphalocele, 29 (76%) survived. 
Postnatal frame of reference 
Including the nineteen (13%) neonates diagnosed after birth, 69 neonates were liveborn. Eight died within 
one week after birth, nine during infancy. Fifty-two (75%) children survived at least two years, and 42 
children participated in our follow-up (Figure 2). One child with minor omphalocele died at three years due 
to volvulus. All children with minor omphalocele underwent primary closure (Table 1).  
 




n = 31 
Giant 
omphalocele 
n = 11 
P - value 
Maternal age (years) A 31 (28-35) 31 (29-33) 0.890 
Male sex 15 (48%) 4 (36%) 0.726 
Multiple pregnancy 3 (10%) 0 (0%) 0.554 
Socio-economic status score at birth 0.08 (-0.53-0.88) 0.06 (-0.95-0.53) 0.463 
- Low status score (<-1) 8 (26%) 2 (18%) 1.000 
Prenatal characteristics    
Prenatal diagnosis 18 (58%) 10 (91%) 0.067 
- Gestational age (weeks) at diagnosis 22.9 (19.5-30.4) 21.2 (15.6-33.4) 0.654 
- OC/AC ≥0.82 at diagnosis 0 (0%) B 8 (73%) <0.001 
- Liver protruding at diagnosis 4 (22%)  9 (90%) 0.001 
Perinatal characteristics    
Caesarean section 8 (26%) 6 (55%) 0.136 
Gestational age at birth (weeks)  38.9 (38.0-39.9) 38.4 (37.0-38.9) 0.163 
Preterm birth  3 (10%) 2 (18%) 0.593 
Birth weight (grams)  3180 (2500-3640) 2750 (2140-3430) 0.124 
Small for gestational age 6 (19%) 3 (27%) 0.676 
Apgar score at 5 min A 10 (9-10) 9 (8-9) 0.043 
- Apgar score <7 at 5 min A 0 (0%) 1 (9%) 0.282 
Postnatal characteristics    
Ruptured omphalocele 5 (16%) 3 (27%) 0.412 
Content of omphalocele C     
- Liver  5 (16%) 11 (100%) <0.001 
- Stomach  0 (0%) 3 (27%) 0.014 
- Bladder  0 (0%) 1 (9%) 0.262 
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Multiple congenital anomalies D 11 (35%) 3 (27%) 0.723 
Primary closure 31 (100%) 1 (9%) E <0.001 
Number of procedures under general anaesthesia F 1 (1-2) 3 (2-5) 0.003 
Duration of initial mechanical ventilation 0 (0-1) 3 (0-119) 0.062 
Chronic lung disease 0 (0%) 6 (55%) <0.001 
Time to full enteral feeding (days) 6 (3-9) 20 (13-49) <0.001 
- Intestinal failure G 2 (6%) 3 (27%) 0.103 
Length of initial hospital stay (days)  7 (5-13) 50 (23-108) <0.001 
Paediatric physiotherapy    
- At 12 months of age 4 (13%) H 6 (55%) 0.013 
- At 24 months of age 2 (7%) I 2 (18%) 0.300 
Data presented as n (%) or median (interquartile range). OC/AC: omphalocele circumference / abdominal 
circumference. A Unknown in n=3 minor omphalocele; B unknown in n=4 prenatally diagnosed minor omphalocele; C 
Percentages do not necessarily add up to 100, as multiple organs can be herniated; D Minor omphalocele: 
cryptorchidism (n=1); cryptorchidism + ren arcuatus (n=1); Beckwith-Wiedemann Syndrome (n=4); enlarged 
monokidney (n=1); intestinal atresia (n=2); intestinal atresia + microcolon (n=1); ileal cyst (n=1); Giant omphalocele: 
Beckwith-Wiedemann Syndrome (n=1); aortic stenosis (n=1); cryptorchidism + epiglottic dysfunction (n=1); E ruptured 
omphalocele; F unknown in n=1 minor omphalocele. G Time to full enteral feeding: 49->730 days. Minor omphalocele: 
intestinal atresia (n=1); intestinal atresia + microcolon (n=1); Giant omphalocele: respiratory insufficiency due to 
sepsis, therefore nil per os (n=1); intestinal passage problems (n=2). H unknown in n=1 (no follow-up at 12 months); I 
unknown in n=2 (no follow-up at 24 months). 
 
Of eleven children with giant omphalocele, one underwent primary closure and ten had definitive closure 
at a median age of 19 months (range: 13-95). Children with giant omphalocele needed three times as many 
procedures under general anaesthesia as those with minor omphalocele. While more than half of the 
children with giant omphalocele developed chronic lung disease, none of those with minor omphalocele 
did. Three children with giant omphalocele needed mechanical ventilation for over 100 days; all got a 
tracheostomy cannula. The others breathed spontaneously within one week. Median TFEF was less than 
one week in neonates with minor omphalocele. TFEF was three times longer in those with giant 
omphalocele; almost one third developed intestinal failure. Children with giant omphalocele stayed seven 
times longer in hospital than those with minor omphalocele (Table 1).  
Physical growth and neurodevelopment 
Height and weight SDS are shown in Figure 3. The general linear model analysis showed no 
significant differences over time. At 12 months, the estimated marginal mean height SDS was significantly 
below 0 in children with giant omphalocele (-1.24 [95% CI: -2.01, -0.46]); weight SDS fell significantly below 
0 both in children with minor (-0.61 [-1.04, -0.18]) and in those with giant omphalocele (-1.49 [-2.20, -
0.78]). At 24 months, height and weight SDS were significantly below 0 in both children with minor 
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omphalocele (height: -0.57 [-1.05, -0.09]; weight: -0.86 [-1.35, -0.37]) and in those with giant omphalocele 
(height: -1.32 [-2.10, -0.54]; weight: -1.58 [-2.37, -0.79]). 
Head circumference SDS was measured in 23 children with minor omphalocele (median [IQR]: -0.56 
[-0.89, 0.42]), and in six with giant omphalocele (-0.22 [-1.18, -0.05]), with no statistically significant 
difference between those groups (p=0.854).  
 
Figure 3. Height and weight standard deviation scores (SDS) of children with minor or giant omphalocele.  
Symbols represent estimated marginal means with 95% confidence intervals, based on a general linear model that 
includes age, type of omphalocele, and their interaction term as explanatory variables.  
At 12 months, height SDS was <-2 in 1/26 (4%) children with minor and in 2/9 (22%) children with giant omphalocele. 
Weight SDS was <-2 in 3/26 (12%) children with minor and in 4/9 (44%) children with giant omphalocele. 
At 24 months, height SDS was <-2 in 2/25 (8%) children with minor and in 3/10 (30%) children with giant omphalocele. 
Weight SDS was <-2 in 4/25 (16%) children with minor and in 4/10 (40%) children with giant omphalocele. 
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The estimated marginal mean MDI was comparable to reference norms at both time points in 
children with minor omphalocele (12 months: 106 [100, 112]; 24 months: 100 [93, 108]) and in those with 
giant omphalocele (12 months: 97 [87, 107]; 24 months: 98 [86, 110]), and did not differ between these 
groups. The mean PDI in children with minor omphalocele was significantly below 100 but within the 
normal range of 85-115, both at 12 months (89 [82, 95]) and 24 months (93 [87, 99]). PDI in those with 
giant omphalocele was significantly below normal at both time points (12 months: 75 [65, 86]; 24 months: 
77 [69, 86]); overall, children with giant omphalocele scored 15 [5, 26] points less than those with minor 
omphalocele. At 24 months, motor developmental delay occurred significantly more often in children with 

















Figure 4. Proportions of children with minor or giant omphalocele with normal or delayed mental (left 
panel) and motor (right panel) at 12 and 24 months of follow-up.  




At 12 months, four (13%) children with minor and six (55%) with giant omphalocele received 
physiotherapy at home. This was continued up to at least 24 months in two (7%) children with minor and 
two (18%) with giant omphalocele.  
DISCUSSION 
We evaluated the course of omphalocele from diagnosis to growth and development at two years of age. 
As we hypothesized, the prenatal frame of reference was considerably worse than that after birth; 
additional structural or chromosomal anomalies–mainly lethal–were found in more than half of the fetuses. 
Physical growth at two years mainly fell within normal range. Mental development was generally normal. 
Motor development was delayed in over 80% of children with giant omphalocele.  
The two-year survival rate in liveborn neonates was 75%, which is in concordance with previous 
literature.(4, 20) The two-year survival rate in prenatally diagnosed omphalocele was almost three times as 
low, causing a considerable difference between prenatal and postnatal frame of reference of this anomaly. 
The low survival rate in prenatally diagnosed omphalocele was mainly determined by the high prevalence 
of additional anomalies, and concomitantly high rate of TOP. In addition, IUD and neonatal death occurred 
frequently in this group, which confirms previous literature.(21-23)  
The OC/AC-ratio is intended to provide individualised counselling by predicting type of closure.(12) 
In our study, many parents of fetuses with an isolated omphalocele and OC/AC ≥0.82 opted for TOP. In the 
continuing pregnancies, IUD occurred in 29%. In fetuses with OC/AC <0.82, the rates of TOP and IUD were 
much lower. Earlier studies on omphalocele ratios only included liveborn neonates (12, 24-26) or were 
unable to distinguish between isolated and non-isolated omphalocele due to small sample sizes.(27) Our 
finding that the OC/AC-ratio may predict survival requires further research.  
This study emphasizes the importance of a multidisciplinary approach in parental counselling; 
paediatric surgeons and paediatricians may be more optimistic about survival rates than obstetricians and 
prenatal specialists. Moreover, inclusion criteria in studies on survival rates in omphalocele should be 
considered accurately: those including only prenatally diagnosed children are more likely to report lower 
survival rates than those including all children with omphalocele.  
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Previous studies on physical growth in children with AWD–not distinguishing between gastroschisis 
and omphalocele–reported suboptimal growth in infancy(10, 11), and normal(28) or suboptimal(9) growth 
in childhood. Henrich and coworkers reported weight <p3 in 3/15 (20%) children with omphalocele aged 1-
10 years, and height <p3 in two (13%) children.(29) These proportions are similar to our results in two-year 
olds, and higher than those in the reference population (i.e. 2.3%, based on a standard normal distribution). 
Although their height and weight fell within the normal range at both time points, children with 
omphalocele seem to be at greater risk of failure to thrive. Our data did not allow for conclusions regarding 
determinants of poor growth. We assume that several aspects play a role, including neonatal surgery, work 
of breathing, prolonged hospitalisation, and impaired mother-child interaction. We recommend close 
monitoring of growth, and early nutritional intervention if necessary.  
 Neurodevelopment has previously been studied in cohorts combining different types of non-cardiac 
anatomical anomalies(8, 30, 31) or AWD,(9-11) and in cohorts limited to giant omphalocele.(5-7) Similar to 
our results, Burnett and coworkers reported motor function delay in two-year old children with 
omphalocele.(32) Studies that did not differentiate between non-cardiac anatomical anomalies reported 
high prevalences of neurodevelopmental problems.(8, 30, 31) In contrast, studies that evaluated children 
with AWD showed normal neurodevelopment in infancy,(10, 11) and normal motor development in 
childhood.(9) Note, however, that gastroschisis and omphalocele are two different entities; the prenatal 
and postnatal outcomes of children with omphalocele included in the present study differ much from those 
in children with gastroschisis in our previous study.(33)  
Parental counselling should stress the importance of the difference between giant and minor 
omphalocele, as we found that giant omphalocele carried a greater risk of motor developmental delay. A 
previous study reported both mental and motor developmental delay in more than half of 31 children with 
giant omphalocele aged 6-35 months.(6) We suspect the higher proportion of mental developmental delay 
could be explained by the inclusion of children with major MCA and rare syndromes in that study.(6) 
We assume that in many children with giant omphalocele, the ventral hernia and altered trunk 
stability—due to abnormal development of the anterior abdominal muscles—contribute to impaired motor 
development in infancy, with a catch-up effect in childhood. A previous study reported normal motor 
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function in children with giant omphalocele aged 3.5-12 years.(5) Nevertheless, monitoring of motor 
development in children with giant omphalocele with timely interventions if needed may be helpful. 
Moreover, parents should be encouraged to stimulate physical activity and should be counselled on leisure 
and sport participation of their children. 
Strengths of our study are the data collection from a longitudinal prospective follow-up programme 
of mostly prenatally diagnosed children; the high proportion (81%) of children that entered this 
programme; the relatively large sample size for such a rare disease; and the use of standardized 
assessments both prenatally and during follow-up. Several limitations need to be addressed. First, the 
sample size was too small to study determinants of neurodevelopmental delay. Second, we compared 
height SDS to reference norms rather than to target height SDS, as parental height was often missing.  
In conclusion, the prenatal frame of reference of omphalocele differs considerably from the frame 
of reference after birth, and a multidisciplinary approach in parental counselling is recommended. As two-
year old children with giant omphalocele often had delayed motor development, we recommend timely 
referral to a paediatric physical therapist and prolonged follow-up, at least until these children have 
reached school age.  
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What is already known on this topic 
1. Fetuses and neonates with an isolated omphalocele usually have a good prognosis. 
2. Longitudinal data on growth and neurodevelopment in children with minor and giant omphalocele 
are scarce.  
 
 
What this study adds  
1. The prenatal and postnatal frame of reference of omphalocele differ considerably; a 
multidisciplinary approach in parental counselling is recommended. 
2. Two-year old children with minor and giant omphalocele have similar growth and mental 
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